p73α isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells

MYCN activation, mainly by gene amplification, is one of the most frequent molecular events in neuroblastoma (NB) oncogenesis, and is associated with increased malignancy and decreased neuronal differentiation propensity. The frequency of concomitant loss of heterozygosity at the 1p36.3 locus, which harbours the p53 anti-oncogene homologue TP73, indicates that MYCN and p73 alterations may cooperate in the pathogenesis of NB. We have previously shown that p73 isoforms are deregulated in NB tumours and that TAp73 co-operates synergistically with p53 for apoptosis of NB cells, whereas ΔNp73 activates the expression of neuronal differentiation genes such as BTG2. Herein, using both ectopic expression and RNA interference-mediated silencing of p73 in MYCN amplified NB cells, we show that p73α isoforms inhibit MYCN expression at both transcript and protein levels, in spite of transactivator effects on MYCN promoter. To explain this paradox, we found that TAp73α exerts negative post-transcriptional effects leading to reduced MYCN mRNA stability. RNA immunoprecipitation experiments suggest that this dominant inhibitory post-transcriptional effect could be due to an interaction between the p73 protein and MYCN mRNA, a hypothesis also raised for the regulation of certain genes by the p53 protein.

[1]  L. J. Maher,et al.  p53 RNA interactions: new clues in an old mystery. , 2007, RNA.

[2]  J. Bourdon,et al.  p53 and its isoforms in cancer , 2007, British Journal of Cancer.

[3]  T. Schlange,et al.  Novel c‐MYC target genes mediate differential effects on cell proliferation and migration , 2007, EMBO reports.

[4]  L. Cassiday,et al.  Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system. , 2006, RNA.

[5]  Florian C. Oberstrass,et al.  Shape-specific recognition in the structure of the Vts1p SAM domain with RNA , 2006, Nature Structural &Molecular Biology.

[6]  Sanjeev Gupta,et al.  Role of p73 in Regulating Human Caspase-1 Gene Transcription Induced by Interferon-γ and Cisplatin* , 2005, Journal of Biological Chemistry.

[7]  Xinbin Chen,et al.  The C-terminal Sterile α Motif and the Extreme C Terminus Regulate the Transcriptional Activity of the α Isoform of p73* , 2005, Journal of Biological Chemistry.

[8]  E. May,et al.  The neurogene BTG2TIS21/PC3 is transactivated by ΔNp73α via p53 specifically in neuroblastoma cells , 2005, Journal of Cell Science.

[9]  C. Dugast-Darzacq,et al.  Mxi1-SRα: a novel Mxi1 isoform with enhanced transcriptional repression potential , 2004, Oncogene.

[10]  H. Haddada,et al.  Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line , 2004, Journal of Cell Science.

[11]  Xinbin Chen,et al.  ΔNp73β Is Active in Transactivation and Growth Suppression , 2004, Molecular and Cellular Biology.

[12]  James U Bowie,et al.  SAM domains: uniform structure, diversity of function. , 2003, Trends in biochemical sciences.

[13]  J. González-Ros,et al.  Binding of the C-terminal Sterile α Motif (SAM) Domain of Human p73 to Lipid Membranes* , 2003, Journal of Biological Chemistry.

[14]  Tzvi Aviv,et al.  The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators , 2003, Nature Structural Biology.

[15]  A. Aggarwal,et al.  RNA recognition via the SAM domain of Smaug. , 2003, Molecular cell.

[16]  W. Hahn,et al.  Chemosensitivity linked to p73 function. , 2003, Cancer cell.

[17]  A. Sadikot,et al.  p73 Is Required for Survival and Maintenance of CNS Neurons , 2002, The Journal of Neuroscience.

[18]  Takao Hayakawa,et al.  Autoinhibitory Regulation of p73 by ΔNp73 To Modulate Cell Survival and Death through a p73-Specific Target Element within the ΔNp73 Promoter , 2002, Molecular and Cellular Biology.

[19]  M. Eilers,et al.  Contributions of Myc to tumorigenesis. , 2002, Biochimica et biophysica acta.

[20]  G. Tonini,et al.  Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients , 2002, Cell Death and Differentiation.

[21]  M. Kaghad,et al.  DeltaN-p73alpha accumulates in human neuroblastic tumors. , 2002, The American journal of pathology.

[22]  L. Créancier,et al.  Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism , 2001, Oncogene.

[23]  M. Perucho,et al.  Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma , 2001, British Journal of Cancer.

[24]  M. Ewen,et al.  p53 Binds Selectively to the 5′ Untranslated Region ofcdk4, an RNA Element Necessary and Sufficient for Transforming Growth Factor β- and p53-Mediated Translational Inhibition of cdk4 , 2000, Molecular and Cellular Biology.

[25]  F. McKeon,et al.  An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. , 2000, Science.

[26]  G. Melino,et al.  Induction of Neuronal Differentiation by p73 in a Neuroblastoma Cell Line* , 2000, The Journal of Biological Chemistry.

[27]  D. Wechsler,et al.  Expression of MXI1, a Myc Antagonist, Is Regulated by Sp1 and AP2* , 1999, The Journal of Biological Chemistry.

[28]  N. Sidell,et al.  Interferon-gamma and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action. , 1997, Cancer letters.

[29]  G. Brodeur,et al.  Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines , 1997, Oncogene.

[30]  A. Yang,et al.  Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.

[31]  B Johansson,et al.  Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. , 1997, Cancer research.

[32]  J. Rossant,et al.  Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus. , 1993, Development.

[33]  R. Brent,et al.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.

[34]  V. Stewart,et al.  Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. , 1992, Genes & development.

[35]  R. Carroll,et al.  The tumor suppressor p53 is bound to RNA by a stable covalent linkage , 1991, Molecular and cellular biology.

[36]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[37]  G. S. Sekhon,et al.  Chromosomal aberrations in human neuroblastomas , 1977, Cancer.

[38]  Xinbin Chen,et al.  The C-terminal sterile alpha motif and the extreme C terminus regulate the transcriptional activity of the alpha isoform of p73. , 2005, The Journal of biological chemistry.

[39]  E. May,et al.  The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells. , 2005, Journal of cell science.

[40]  Xinbin Chen,et al.  DeltaNp73beta is active in transactivation and growth suppression. , 2004, Molecular and cellular biology.

[41]  J. González-Ros,et al.  Binding of the C-terminal sterile alpha motif (SAM) domain of human p73 to lipid membranes. , 2003, The Journal of biological chemistry.

[42]  R. Kuick,et al.  N-myc modulates expression of p73 in neuroblastoma. , 2002, Neoplasia.

[43]  A. Nakagawara,et al.  Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. , 2002, Molecular and cellular biology.